| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.002 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |